Cargando…

Co-targeting WIP1 and PARP induces synthetic lethality in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most fatal cancers. Due to limited strategies for effective treatments, patients with advanced HCC have a very poor prognosis. This study aims to identify new insights in HCC to develop novel strategies for HCC management. METHODS: The role of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Miaoqin, Wang, Weikai, Hu, Shiman, Tong, Yifan, Li, Yiling, Wei, Qi, Yu, Lei, Zhu, Liyuan, Zhu, Yiran, Liu, Leiming, Ju, Zhenyu, Wang, Xian, Jin, Hongchuan, Feng, Lifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962187/ https://www.ncbi.nlm.nih.gov/pubmed/35346236 http://dx.doi.org/10.1186/s12964-022-00850-2

Ejemplares similares

Sirt1 deacetylates and stabilizes p62 to promote hepato-carcinogenesis
por: Feng, Lifeng, et al.
Publicado: (2021)

Targeting nuclear acid-mediated immunity in cancer immune checkpoint inhibitor therapies
por: Chen, Miaoqin, et al.
Publicado: (2020)

CK1δ stimulates ubiquitination‐dependent proteasomal degradation of ATF4 to promote chemoresistance in gastric Cancer
por: Feng, Lifeng, et al.
Publicado: (2021)

Synthetic lethality of glutaminolysis inhibition, autophagy inactivation and asparagine depletion in colon cancer
por: Li, Jiaqiu, et al.
Publicado: (2017)

Targeting ATF4-dependent pro-survival autophagy to synergize glutaminolysis inhibition
por: Han, Shuting, et al.
Publicado: (2021)

EGFR TKIs impair lysosome-dependent degradation of SQSTM1 to compromise the effectiveness in lung cancer
por: Yang, Lixian, et al.
Publicado: (2019)

Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer
por: Zhu, Liyuan, et al.
Publicado: (2019)

Synthetic Lethality of Cohesins with PARPs and Replication Fork Mediators
por: McLellan, Jessica L., et al.
Publicado: (2012)

WIP1 Promotes Homologous Recombination and Modulates Sensitivity to PARP Inhibitors
por: Burdova, Kamila, et al.
Publicado: (2019)

Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer
por: Wang, Weikai, et al.
Publicado: (2023)

The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment
por: Li, Shuangying, et al.
Publicado: (2022)

Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors
por: Mendes-Pereira, Ana M, et al.
Publicado: (2009)

Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
por: Srinivasan, Gayathri, et al.
Publicado: (2017)

Combinatorial targeting of Hippo-STRIPAK and PARP elicits synthetic lethality in gastrointestinal cancers
por: An, Liwei, et al.
Publicado: (2022)

RNA-based therapeutics: an overview and prospectus
por: Zhu, Yiran, et al.
Publicado: (2022)

Predictors and Modulators of Synthetic Lethality: An Update on PARP Inhibitors and Personalized Medicine
por: Murata, Stephen, et al.
Publicado: (2016)

Wnt signaling inhibition confers induced synthetic lethality to PARP inhibitors
por: Angers, Stephane
Publicado: (2021)

Pre-Existing and Acquired Resistance to PARP Inhibitor-Induced Synthetic Lethality
por: Le, Bac Viet, et al.
Publicado: (2022)

Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia
por: Brabson, John P., et al.
Publicado: (2023)

Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells
por: Bajrami, Ilirjana, et al.
Publicado: (2012)

Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
por: Asim, Mohammad, et al.
Publicado: (2017)

RNautophagic regulation of DNMT3a‐dependent DNA methylation by Linc00942 enhances chemoresistance in gastric cancer
por: Zhu, Liyuan, et al.
Publicado: (2023)

Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia
por: Oei, Arlene L., et al.
Publicado: (2017)

XRN2 interactome reveals its synthetic lethal relationship with PARP1 inhibition
por: Patidar, Praveen L., et al.
Publicado: (2020)

The Role of PARP Inhibitors in the Ovarian Cancer Microenvironment: Moving Forward From Synthetic Lethality
por: Turinetto, Margherita, et al.
Publicado: (2021)

Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in BRCA-mutated cancer
por: Li, Peng, et al.
Publicado: (2023)

Tousled-like kinases stabilize replication forks and show synthetic lethality with checkpoint and PARP inhibitors
por: Lee, Sung-Bau, et al.
Publicado: (2018)

Synthetic lethal genetic interactions between Rad54 and PARP-1 in mouse development and oncogenesis
por: Tanori, Mirella, et al.
Publicado: (2016)

Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence
por: Fleury, Hubert, et al.
Publicado: (2019)

Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality
por: Sanese, Paola, et al.
Publicado: (2020)

Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
por: Zatreanu, Diana, et al.
Publicado: (2021)

Targeting the TCA cycle through cuproptosis confers synthetic lethality on ARID1A-deficient hepatocellular carcinoma
por: Xing, Tao, et al.
Publicado: (2023)

LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c‐Myc mRNA stability
por: Zhu, Yiran, et al.
Publicado: (2022)

Phosphatase Wip1 in Immunity: An Overview and Update
por: Shen, Xiao-Fei, et al.
Publicado: (2017)

WIP Remodeling Actin behind the Scenes: How WIP Reshapes Immune and Other Functions
por: Noy, Elad, et al.
Publicado: (2012)

Synthetic Lethal Interactions between EGFR and PARP Inhibition in Human Triple Negative Breast Cancer Cells
por: Nowsheen, Somaira, et al.
Publicado: (2012)

Wip1 regulates hematopoietic stem cell development in the mouse embryo
por: He, Wenyan, et al.
Publicado: (2020)

Hypoxia Stimulates SUMOylation-Dependent Stabilization of KDM5B
por: Zhou, Bingluo, et al.
Publicado: (2021)

TRABID overexpression enables synthetic lethality to PARP inhibitor via prolonging 53BP1 retention at double-strand breaks
por: Ma, Jian, et al.
Publicado: (2023)

In Silico Screening Identifies a Novel Potential PARP1 Inhibitor Targeting Synthetic Lethality in Cancer Treatment
por: Li, Jian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_53q90ogd20snd089cbhr9np3ej